Olanzapine Versus Midazolam for Agitation
Stopped early
Conditions studied: Agitation,Psychomotor
In brief
The goal of this research investigation is to conduct a prospective observation of the comparative efficacy of midazolam versus olanzapine for the treatment of acute undifferentiated agitation in the emergency department.
Key facts
- Study ID
- NCT03899506
- Run by
- Hennepin Healthcare Research Institute
- People needed
- 206
- Starts
- 2018-06-18
- Expected to finish
- 2018-07-16
- Last updated by the study team
- 2019-05-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Emergency Department patients
- Patients 18 years and older
- Patients with acute undifferentiated agitation requiring chemical sedation at the discretion of the attending emergency physician will be observed.
- Patients meeting these criteria who receive medications in the ED will be observed by research staff, evaluating efficacy and safety of the administered medication.
You may not qualify if…
- There are no exclusion criteria per se as this is only observational research. The decision to administer the medication is at the discretion of the physician. Research protocols are only such that we are observing the efficacy and safety, which coincides the quality improvement purposes of this clinical protocol. Patients will be provided an Information Sheet and can opt to have their data removed.
- Patients who are prisoners, children, will NOT have their data collected
Where it is running
- Hennepin County Medical Center — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.